214 related articles for article (PubMed ID: 31932050)
1. Cognitive reserve and rate of change in Alzheimer's and cerebrovascular disease biomarkers among cognitively normal individuals.
Pettigrew C; Soldan A; Zhu Y; Cai Q; Wang MC; Moghekar A; Miller MI; Singh B; Martinez O; Fletcher E; DeCarli C; Albert M
Neurobiol Aging; 2020 Apr; 88():33-41. PubMed ID: 31932050
[TBL] [Abstract][Full Text] [Related]
2. Cognitive reserve and Alzheimer's disease biomarkers are independent determinants of cognition.
Vemuri P; Weigand SD; Przybelski SA; Knopman DS; Smith GE; Trojanowski JQ; Shaw LM; Decarli CS; Carmichael O; Bernstein MA; Aisen PS; Weiner M; Petersen RC; Jack CR;
Brain; 2011 May; 134(Pt 5):1479-92. PubMed ID: 21478184
[TBL] [Abstract][Full Text] [Related]
3. Cognitive reserve and long-term change in cognition in aging and preclinical Alzheimer's disease.
Soldan A; Pettigrew C; Cai Q; Wang J; Wang MC; Moghekar A; Miller MI; Albert M;
Neurobiol Aging; 2017 Dec; 60():164-172. PubMed ID: 28968586
[TBL] [Abstract][Full Text] [Related]
4. CSF amyloid is a consistent predictor of white matter hyperintensities across the disease course from aging to Alzheimer's disease.
Walsh P; Sudre CH; Fiford CM; Ryan NS; Lashley T; Frost C; Barnes J;
Neurobiol Aging; 2020 Jul; 91():5-14. PubMed ID: 32305782
[TBL] [Abstract][Full Text] [Related]
5. White matter hyperintensities and cognition across different Alzheimer's biomarker profiles.
Lam S; Lipton RB; Harvey DJ; Zammit AR; Ezzati A;
J Am Geriatr Soc; 2021 Jul; 69(7):1906-1915. PubMed ID: 33891712
[TBL] [Abstract][Full Text] [Related]
6. Cerebrospinal Fluid Biomarkers and Reserve Variables as Predictors of Future "Non-Cognitive" Outcomes of Alzheimer's Disease.
Ingber AP; Hassenstab J; Fagan AM; Benzinger TL; Grant EA; Holtzman DM; Morris JC; Roe CM
J Alzheimers Dis; 2016; 52(3):1055-64. PubMed ID: 27104893
[TBL] [Abstract][Full Text] [Related]
7. Relationship of cognitive reserve and cerebrospinal fluid biomarkers to the emergence of clinical symptoms in preclinical Alzheimer's disease.
Soldan A; Pettigrew C; Li S; Wang MC; Moghekar A; Selnes OA; Albert M; O'Brien R;
Neurobiol Aging; 2013 Dec; 34(12):2827-34. PubMed ID: 23916061
[TBL] [Abstract][Full Text] [Related]
8. The balance between cognitive reserve and brain imaging biomarkers of cerebrovascular and Alzheimer's diseases.
Murray AD; Staff RT; McNeil CJ; Salarirad S; Ahearn TS; Mustafa N; Whalley LJ
Brain; 2011 Dec; 134(Pt 12):3687-96. PubMed ID: 22102649
[TBL] [Abstract][Full Text] [Related]
9. Longitudinal structural cerebral changes related to core CSF biomarkers in preclinical Alzheimer's disease: A study of two independent datasets.
Falcon C; Tucholka A; Monté-Rubio GC; Cacciaglia R; Operto G; Rami L; Gispert JD; Molinuevo JL;
Neuroimage Clin; 2018; 19():190-201. PubMed ID: 30023169
[TBL] [Abstract][Full Text] [Related]
10. Application of the NIA-AA Research Framework: Towards a Biological Definition of Alzheimer's Disease Using Cerebrospinal Fluid Biomarkers in the AIBL Study.
Burnham SC; Coloma PM; Li QX; Collins S; Savage G; Laws S; Doecke J; Maruff P; Martins RN; Ames D; Rowe CC; Masters CL; Villemagne VL
J Prev Alzheimers Dis; 2019; 6(4):248-255. PubMed ID: 31686097
[TBL] [Abstract][Full Text] [Related]
11. Neuronal injury biomarkers for assessment of the individual cognitive reserve in clinically suspected Alzheimer's disease.
Beyer L; Schnabel J; Kazmierczak P; Ewers M; Schönecker S; Prix C; Meyer-Wilmes J; Unterrainer M; Catak C; Pogarell O; Perneczky R; Albert NL; Bartenstein P; Danek A; Buerger K; Levin J; Rominger A; Brendel M
Neuroimage Clin; 2019; 24():101949. PubMed ID: 31398553
[TBL] [Abstract][Full Text] [Related]
12. Cognitive Effects of White Matter Pathology in Normal and Pathological Aging.
Kaskikallio A; Karrasch M; Rinne JO; Tuokkola T; Parkkola R; Grönholm-Nyman P
J Alzheimers Dis; 2019; 67(2):489-493. PubMed ID: 30594927
[TBL] [Abstract][Full Text] [Related]
13. Relationship between cerebrospinal fluid biomarkers of Alzheimer's disease and cognition in cognitively normal older adults.
Pettigrew C; Soldan A; Moghekar A; Wang MC; Gross AL; O'Brien R; Albert M
Neuropsychologia; 2015 Nov; 78():63-72. PubMed ID: 26394023
[TBL] [Abstract][Full Text] [Related]
14. Adverse Vascular Risk Relates to Cerebrospinal Fluid Biomarker Evidence of Axonal Injury in the Presence of Alzheimer's Disease Pathology.
Osborn KE; Alverio JM; Dumitrescu L; Pechman KR; ; Gifford KA; Hohman TJ; Blennow K; Zetterberg H; Jefferson AL
J Alzheimers Dis; 2019; 71(1):281-290. PubMed ID: 31381510
[TBL] [Abstract][Full Text] [Related]
15. Small vessel cerebrovascular disease is associated with cognition in prospective Alzheimer's clinical trial participants.
Morales CD; Cotton-Samuel D; Lao PJ; Chang JF; Pyne JD; Alshikho MJ; Lippert RV; Bista K; Hale C; Edwards NC; Igwe KC; Deters K; Zimmerman ME; Brickman AM
Alzheimers Res Ther; 2024 Feb; 16(1):25. PubMed ID: 38308344
[TBL] [Abstract][Full Text] [Related]
16. Association of Altered Liver Enzymes With Alzheimer Disease Diagnosis, Cognition, Neuroimaging Measures, and Cerebrospinal Fluid Biomarkers.
Nho K; Kueider-Paisley A; Ahmad S; MahmoudianDehkordi S; Arnold M; Risacher SL; Louie G; Blach C; Baillie R; Han X; Kastenmüller G; Trojanowski JQ; Shaw LM; Weiner MW; Doraiswamy PM; van Duijn C; Saykin AJ; Kaddurah-Daouk R;
JAMA Netw Open; 2019 Jul; 2(7):e197978. PubMed ID: 31365104
[TBL] [Abstract][Full Text] [Related]
17. Cerebrovascular disease promotes tau pathology in Alzheimer's disease.
Laing KK; Simoes S; Baena-Caldas GP; Lao PJ; Kothiya M; Igwe KC; Chesebro AG; Houck AL; Pedraza L; Hernández AI; Li J; Zimmerman ME; Luchsinger JA; Barone FC; Moreno H; Brickman AM;
Brain Commun; 2020; 2(2):fcaa132. PubMed ID: 33215083
[TBL] [Abstract][Full Text] [Related]
18. Utility of an Alzheimer's Disease Risk-Weighted Polygenic Risk Score for Predicting Rates of Cognitive Decline in Preclinical Alzheimer's Disease: A Prospective Longitudinal Study.
Porter T; Burnham SC; Milicic L; Savage G; Maruff P; Lim YY; Li QX; Ames D; Masters CL; Rainey-Smith S; Rowe CC; Salvado O; Groth D; Verdile G; Villemagne VL; Laws SM;
J Alzheimers Dis; 2018; 66(3):1193-1211. PubMed ID: 30412495
[TBL] [Abstract][Full Text] [Related]
19. Association Between Longitudinal Plasma Neurofilament Light and Neurodegeneration in Patients With Alzheimer Disease.
Mattsson N; Cullen NC; Andreasson U; Zetterberg H; Blennow K
JAMA Neurol; 2019 Jul; 76(7):791-799. PubMed ID: 31009028
[TBL] [Abstract][Full Text] [Related]
20. Beneficial effect of bilingualism on Alzheimer's disease CSF biomarkers and cognition.
Estanga A; Ecay-Torres M; Ibañez A; Izagirre A; Villanua J; Garcia-Sebastian M; Iglesias Gaspar MT; Otaegui-Arrazola A; Iriondo A; Clerigue M; Martinez-Lage P
Neurobiol Aging; 2017 Feb; 50():144-151. PubMed ID: 27916386
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
